D3 pre-mRNA processing in chronic psychosis
D3 pre-mRNA processing in chronic psychosis
批准号:
6998949
负责人:
CLAUDIA SCHMAUSS
金额:
$23.08万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2007-11-30
关键词:
RNA splicingRNase protection assaybehavioral /social science research tagbrain mappingclinical researchcognitiondopamine receptorfos proteingene expressionhuman tissueimmunocytochemistryimmunoprecipitationintermolecular interactionlaboratory mousemolecular assembly /self assemblyneurogeneticsneuropathologyneurophysiologyneuropsychologynucleic acid structurephospholipase Cpostmortemprecursor mRNAprotein isoformsprotein structure functionschizophrenia
中文摘要
描述(由申请人提供):
在慢性精神病患者的大脑中,
多巴胺D3受体编码的前体mRNA的选择性剪接导致
D3受体mRNA表达显著降低,
选择性剪接、截短的D3样mRNA(命名为D3 nf)的积累
D3 nf mRNA被翻译成一种蛋白质,
与全长D3受体蛋白组装。与单体和
同源寡聚体D3蛋白,D3 ID 30 f异源寡聚体不结合配体,
高亲和力。因此,两者都增强了D3-前mRNA的选择性剪接,
D3/D3 nf蛋白异源寡聚体组装导致
功能性D3受体这一竞争性的更新旨在扩大我们以前的
大鼠死后脑皮质D3和D3 nf mRNA相对表达的研究
新的精神分裂症患者及其匹配人群的区域
对照进一步的研究使用体内RNA剪接测定结合
底物D3前体mRNA,以测试磷脂酶C活性在
D3和D3 NF特异性剪接位点选择的调节。其他研究
使用基因敲除小鼠研究D3受体失活的功能后果。
我们的研究表明,D3受体失活会导致
至少两种调节神经元活性的基因(c-fos,
钙结合蛋白)在解剖结构中的作用,
精神分裂症中易受破坏的过程。因此,一系列
解剖学和生物化学研究的目的是阐明导致
D1-受体介导的c-fos反应在缺乏
D3和D2受体。对这些突变体的进一步行为研究
测试这种D1受体活性的降低是否会对他们的
在认知任务中的表现最后一系列的免疫细胞化学
实验测试纹状体钙结合蛋白的表达是否
蛋白质钙结合蛋白在D3突变体中减少,因为D3受体表达
促进共表达D3的腹侧纹状体神经元中的钙结合蛋白表达
受体和钙结合蛋白,或者因为D3受体在细胞内发挥更普遍的作用。
纹状体钙结合蛋白表达系统的出生后发育。
英文摘要
DESCRIPTION (provided by applicant):
In brains of patients with chronic psychosis, an abnormally increased
alternative splicing of dopamine D3 receptor-encoded pre-mRNA leads to a
significant decrease in the expression of D3 receptor mRNA and an increased
accumulation of the alternatively-spliced, truncated D3-like mRNA, named D3nf
D3nf mRNA is translated into a protein that participates in heteroligomeric
assemblies with full-length D3-receptor protein. In contrast to monomeric and
homoligomeric D3 proteins, the D3ID30f heteroligomers do not bind ligands with
high affinity. Thus, both enhanced alternative splicing of D3-pre-mRNA and the
heteroligomeric assembly of D3/D3nf proteins lead to a decreased expression of
functional D3 receptors. This competing renewal seeks to extend our previous
postmortem study on the relative expression of D3 and D3nf mRNAs in cortical
regions of a new population of schizophrenic patients and their matched
controls. Further studies use in vivo RNA splicing assays in conjunction with
substrate D3 pre-mRNA to test the role of phospholipase C activity in the
regulation of D3- and D3nf-specific splice-site selections. Additional studies
use knockout mice to study functional consequences of D3 receptor inactivation.
Our studies have shown that D3 receptor inactivation leads to a decreased
expression of at least two genes that modulate neuronal activity (c-fos,
calbindin) in anatomic structures critically involved in those cognitive
processes that are vulnerable to disruption in schizophrenia. Thus, one series
of anatomic and biochemical studies aims at elucidating mechanisms that lead to
a decreased D1-receptor-mediated neocortical c-fos response in mice deficient
for D3 and D2 receptors. Additional behavioral studies on these mutants further
test whether this decreased D1-receptor activity has consequences for their
performance in cognitive tasks. A final series of immunocytochemical
experiments tests whether the expression of the striatal calcium-binding
protein calbindin is decreased in D3 mutants because D3 receptor expression
promotes calbindin expression in ventral striatal neurons that co-express D3
receptors and calbindin or because D3-receptors play a more general role in the
postnatal development of the striatal calbindin-expressing system.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s00213-012-2896-5
发表时间:
2013-03
期刊:
PSYCHOPHARMACOLOGY
影响因子:
3.4
作者:
[Zimnisky, Ross, Chang, Gloria, Gyertyan, Istvan, Kiss, Bela, Adham, Nika, Schmauss, Claudia]
通讯作者:
Schmauss, Claudia
DOI:
10.1016/j.neuroscience.2009.04.052
发表时间:
2009-08-04
期刊:
NEUROSCIENCE
影响因子:
3.3
作者:
[Desteno, D. A., Schmauss, C.]
通讯作者:
Schmauss, C.
Epigenetic modulation of antidepressant efficacy
-
批准号:8706970
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
Epigenetic modulation of antidepressant efficacy
-
批准号:8582998
-
项目类别:
-
资助金额:$24.0万
-
财政年份:2013
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
Genetic and environmental modulation of RNA editing
-
批准号:7743836
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2008
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
Genetic and environmental modulation of RNA editing
-
批准号:7991781
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2008
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
Genetic and environmental modulation of RNA editing
-
批准号:7563296
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2008
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
5-HT2C-receptor expression and function in depression
-
批准号:6325053
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2001
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
5-HT2C-receptor expression and function in depression
-
批准号:6539139
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2001
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
5-HT2C-receptor expression and function in depression
-
批准号:6639197
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2001
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
5-HT2C receptor expression and function in depression
-
批准号:7120761
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2000
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 pre-mRNA processing in chronic psychosis
-
批准号:6832176
-
项目类别:
-
资助金额:$23.63万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
-
批准号:2864068
-
项目类别:
-
资助金额:$10.42万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
-
批准号:2675535
-
项目类别:
-
资助金额:$6.26万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
-
批准号:2034927
-
项目类别:
-
资助金额:$16.86万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
-
批准号:6186634
-
项目类别:
-
资助金额:$17.8万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
-
批准号:2890844
-
项目类别:
-
资助金额:$17.28万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 pre-mRNA processing in chronic psychosis
-
批准号:6430562
-
项目类别:
-
资助金额:$27.22万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 pre-mRNA processing in chronic psychosis
-
批准号:6621109
-
项目类别:
-
资助金额:$26.13万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
D3 pre-mRNA processing in chronic psychosis
-
批准号:6689984
-
项目类别:
-
资助金额:$23.63万
-
财政年份:1997
-
负责人:CLAUDIA SCHMAUSS
-
依托单位:
海外基金